Fig. 4
From: The potential of chimeric antigen receptor -T cell therapy for endocrine cancer
The figure illustrates the main challenges associated with CAR-T cell therapy for various endocrine cancers. These challenges include off-target effects, tumor antigen escape, tumor heterogeneity, cytokine release syndrome, and the immunosuppressive tumor microenvironment (TME)